Skip to main content

Neurome to Acquire TOGA Gene-Expression Platform, All Other Assets from Digital Gene Technologies

NEW YORK, Aug. 11 (GenomeWeb News) - Neurome plans to buy "substantially all" the assets owned by Digital Gene Technologies, including its gene-expression assays and gene-expression-analysis platform called TOGA, the companies said yesterday.

 

Neurome, which develops databases that depict and integrate gene-expression patterns of the brain, will also acquire DGT's entire patent estate. This includes data and discoveries generated in commercial and academic research programs.

Terms of the acquisition were not disclosed.

 

Neurome and DGT are both based in La Jolla, Calif.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.